Drug Name Differin

In small amounts, cyanide can be converted to the relatively nontoxic thiocyanate (SCN-) by hepatic “rhodanese” or sulfur transferase. As a therapeutic measure, thiosulfate can be given i. v. to promote formation of thiocyanate, which is eliminated in urine. However, this reaction is slow in onset.
Although simple to perform, these binding assays pose the difficulty of correlating unequivocally the binding sites concerned with the pharmacological effect; this is particularly difficult when more than one population of binding sites is present.

 

The success of infarct therapy critically depends on the length of time between the onset of the attack and the start of treatment. Whereas some therapeutic measures are indicated only after the diagnosis is confirmed, others necessitate prior exclusion of contraindications or can be instituted only in specially equipped facilities.
The most common unwanted effect is gastrointestinal upset (nausea, vomiting, diarrhea, etc. ) due to (1) a direct mucosal irritant action of these substances and (2) damage to the natural bacterial gut flora (broad-spectrum antibiotics) allowing colonization by pathogenic organisms, including Candida fungi.